ArticleInternational journal of epidemiology2025
Sample-size determination for decentralized clinical trials.
Article in International journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundDecentralized clinical trials (DCTs) are increasingly recognized and utilized in epidemiology studies and drug development. A critical step in designing DCTs is determining the sample size-a topic that is insufficiently covered in the literature. This paper aims to propose a sample-size-calculation method for designing DCTs.
methodsA key challenge in analysing DCTs is that data collected onsite and offsite may differ in both variance and mean. The proposed approach employs the weighted z-test to account for such heterogeneity and combines test statistics based on onsite and offsite data. Closed-form sample-size formulas are derived for both cross-sectional studies with independent data and longitudinal or cluster studies with correlated data. The validity of the method is demonstrated by using two examples: cardiovascular disease and pain-management trials.
resultsOur theoretical derivations and numerical studies show that the proposed method enables accurate and robust sample-size determination for DCTs across varying effect sizes, intraclass correlation coefficients for correlated data, variances of onsite and offsite measurements, and ratios of onsite and offsite patients. Compared with the conventional sample-size formula developed for traditional trials involving onsite patients only, the proposed method offers more precise sample-size determination and better preservation of the study power.
conclusionThe proposed method offers an accurate and easy-to-use tool, supported by user-friendly software, for determining sample sizes for DCTs, encompassing both cross-sectional and longitudinal or cluster trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.